Products for Research Use Only
RegisterLogin

Cbl-b-IN-30

CAT: 0804-HY-179617Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179617Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cbl-b-IN-30 is an orally active Casitas B-lineage lymphoma-b (CBLB) inhibitor. Cbl-b-IN-30 specifically binds to CBLB and inhibits its E3 ubiquitin ligase activity with an IC50 of 9.1 nM. Cbl-b-IN-30 can promote IL-2 secretion (EC50 = 187.5 nM) and enhance T cell activation. Cbl-b-IN-30 exerts antitumor activity and can induce immune memory. Cbl-b-IN-30 can be used for the research of colon cancer[1].
UNSPSC
12352005
Target
E1/E2/E3 Enzyme; Interleukin Related
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
C[C@@H]1C[C@@](C2=NN=CN2C)(C3=CC=NC(N4C=NC(C(C(F)(F)F)=CC(CN5CCC[C@@H](C5)C)=C6)=C6C4=O)=C3)C1
Molecular Formula
C29H32F3N7O
Molecular Weight
551.61
References & Citations
[1]Meng F, et al. Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB Inhibitors. J Med Chem. 2025;68 (22) :24502-24518.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-2

Related Products

CatalogName
HY-179575Cbl-b-IN-29
HY-159615Cbl-b-IN-21
HY-163194Cbl-b-IN-16
HY-169005Cbl-b-IN-27
HY-156764Cbl-b-IN-8
HY-158174Cbl-b-IN-20
HY-156768-01Cbl-b-IN-12
HY-156763Cbl-b-IN-7
HY-161977-01Cbl-b-IN-26
HY-155477-01Cbl-b-IN-15

Alternative Products

CatalogName
GTR19273925-01Cbl-b-IN-30
sc-376409Cbl-b (B-5)
BA7372-1Cbl-b-IN-1
BA7392-25Cbl-b-IN-5
T209801-01Cbl-b-IN-20
T209659-01Cbl-b-IN-17
T209172-01Cbl-b-IN-16
T200325-01Cbl-b-IN-26
T79900-01Cbl-b-IN-13
T79899-01Cbl-b-IN-12

Popular Products